Ribhav Mishra

Employment

• Purdue University West Lafayette Post-Doctoral Fellow
  2024 - Present
• Enveda Therapeutics (United States) Scientist
  2021 - 2023
• Northwestern University Feinberg School of Medicine Post-Doctoral Fellow
  2020 - 2021

Education

• Indian Institute of Technology Jodhpur Ph.D. in Bioscience and Bioengineering
  2014 - 2019

Projects & Funding

Projects & funding information is unavailable.

Publications (24)

• Exosomes in Amyloid Propagation—Roles in Neurodegeneration
  Molecular Neurobiology 2026 DOI: 10.1007/s12035-026-05913-w
  +Save
• An update on mammalian and non-mammalian animal models for biomarker development in neurodegenerative disorders
  Cellular and Molecular Life Sciences 2025 DOI: 10.1007/s00018-025-05668-y
  +Save
• The role of stem cells in the study and treatment of neurodegenerative diseases with environmental etiology
  Advances in Neurotoxicology 2024 DOI: 10.1016/bs.ant.2024.07.001
  +Save
• LISTERIN E3 Ubiquitin Ligase and Ribosome-Associated Quality Control (RQC) Mechanism
  Molecular Neurobiology 2021 DOI: 10.1007/s12035-021-02564-x
  +Save
• LRSAM1 E3 ubiquitin ligase promotes proteasomal clearance of E6-AP protein
  Cellular Signalling 2021 DOI: 10.1016/j.cellsig.2020.109836
  +Save
• Ubiquitin ligase LRSAM1 suppresses neurodegenerative diseases linked aberrant proteins induced cell death
  International Journal of Biochemistry and Cell Biology 2020 DOI: 10.1016/j.biocel.2020.105697
  +Save
• Rationally designed small molecules targeting toxic CAG repeat RNA that causes Huntington's disease (HD) and spinocerebellar ataxia (SCAs).
  Biochimie 2019 DOI: 10.1016/j.biochi.2019.05.001
  +Save
• Polyphenolic flavonoid (Myricetin) upregulated proteasomal degradation mechanisms: Eliminates neurodegenerative proteins aggregation
  2019 DOI: 10.1002/jcp.28695
  +Save
• LRSAM1 E3 ubiquitin ligase: molecular neurobiological perspectives linked with brain diseases.
  Cellular and molecular life sciences : CMLS 2019 DOI: 10.1007/s00018-019-03055-y
  +Save
• Discovery of a potent small molecule inhibiting Huntington’s disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein
  Scientific Reports 2019 DOI: 10.1038/s41598-019-53410-z
  +Save